University of South Florida

Posts Tagged EPI-743

Patients at center of 8th annual FARA-USF scientific symposium

Patients have always been the center of the yearly scientific symposium hosted by the Friedreich’s Ataxia Research Alliance (FARA) and the University of South Florida Ataxia Research Center. […]

FDA fast tracks Friedreich’s ataxia drug undergoing testing in USF-led trial

The U.S. Food and Drug Administration yesterday designated fast-track status to EPI-743 for the treatment of Friedreich’s ataxia – a move that will help accelerate clinical development of […]

Edison, FARA and USF announce EPI-743 Phase 2 Friedreich’s ataxia clinical trial in adults with point mutations

First patient enrolled to evaluate investigational drug’s effectiveness  in rare Friedreich’s ataxia genotype Mountain View, CA; Downingtown, PA; & Tampa, FL (Nov. 4, 2013) — Edison Pharmaceuticals, the […]

Network-wide options by YD - Freelance Wordpress Developer